Background

Healthcare is currently making a historic transition towards personalized medicine, a new and emerging healthcare model for treatment and prevention strategies tailored towards the client’s specific

On Monday, October 22, 2018 the Departments of Health and Human Services (HHS) and the Treasury issued new guidance pertaining to state waivers under Section 1332

The results of a 2017 survey from the Centers for Disease Control and Prevention (CDC) were released earlier this month, finding that the percent of U.S.

Introduction

Inside a decade, the U.S. Food & Drug Administration (FDA) will approve clinical trials for the genomic modification of a viable human embryo in order